The ABA/BNA Lawyers’ Manual on Professional Conduct™ is a trusted resource that helps attorneys understand cases and decisions that directly impacts their work, practice ethically, and...
By Samson Habte
Aug. 18 — An inventor who lost a patent case after an adverse ruling on a question of first impression may proceed with malpractice claims against his lawyers, the U.S. Court of Appeals for the District of Columbia Circuit ruled in an Aug. 12 opinion that gave a narrow reading to the “judgmental immunity” doctrine ( Seed Co. v. Westerman, 2016 BL 261489, D.C. Cir., No. 14-7126, 8/12/16 , rev'g 30 Law. Man. Prof. Conduct 521).
The decision highlights the fuzzy contours of the judgmental immunity defense, which has gained recognition across the nation in recent years.
That doctrinal defense—sometimes referred to as the “attorney judgment” rule—insulates lawyers from liability in malpractice cases that are predicated on claims that an attorney made the wrong decision when confronted with an unsettled question of law or a tactical choice between multiple viable strategies.
A trial judge previously held that the doctrine required the dismissal of a lawsuit that accused lawyers at a now-defunct firm of making mistakes that doomed a Japanese inventor's efforts to establish the priority of his patent application for a “corrective tape dispenser.”
The client, who first patented his invention in Japan, lost a patent interference proceeding in the U.S. because his lawyers failed to attach an English translation to the patent application they filed in this country.
That oversight prevented the client from using the date of his Japanese application as the filing date for his U.S. application, and it ultimately prevented him from establishing the priority of his invention.
But the trial court said the mistake didn't give rise to malpractice liability because authorities available when the lawyers filed the application didn't make it clear that an English translation was required.
“ Biomet requires that lawyers must exercise reasonable care, but does not require them to foretell the future,” the trial court said, citing a 2009 case that recognized the judgmental immunity defense in D.C. See Biomet Inc. v. Finnegan Henderson LLP, 967 A.2d 662, 25 Law. Man. Prof. Conduct 187 (D.C. 2009).
The appellate court reversed. Through Judge Srikanth Srinivasan, the panel said a jury must decide whether the defendants established the two elements required to invoke judgmental immunity.
“To affirm, we would need to find no genuine dispute of material fact about either of the elements of the doctrine: ‘that (1) the alleged error is one of professional judgment, and (2) the attorney exercised reasonable care in making his or her judgment,'” Srinivasan wrote. “Because we find a genuine issue as to both, we reverse the grant of summary judgment.”
The appeals court said the ambiguity that previously existed regarding whether a foreign translation was required “does not necessarily support the defendants' claim that they exercised judgment in failing to file a translation.”
“Typically, the judgmental-immunity doctrine applies when a lawyer makes a strategic choice between two options, each of which has costs and benefits,” Srinivasan wrote. “For example, in Biomet, the defendant lawyer had to decide which arguments to include in the limited space in his appellate brief.”
“But an attorney does not exercise professional judgment when she interprets unsettled law in a way that ‘manifestly risk[s] the loss of [a] client's claims' for no plausible advantage,” Srinivasan added.
Accordingly, he said, “A factfinder could infer that a reasonable lawyer would err on the side of caution by filing the translation if the requirements were ambiguous and there were no reason not to do so.”
The court said it also wasn't clear that the defendants satisfied the “reasonable care” element of the judgmental immunity defense.
“To fall under the judgmental-immunity doctrine, the lawyer must ‘undertak[e] reasonable research of the relevant legal princip[les] and facts of the given case,'” Srinivasan wrote, citing Biomet.
But the defendants “introduced no evidence of their deliberative process in reaching the decision not to file the translation,” Srinivasan said. “Although the absence of evidence is not necessarily dispositive, it at least permits a factfinder to draw an inference that [the] defendants did not exercise reasonable care,” he wrote.
Plaintiff Shigeru Tamai and his company, Seed Co. Ltd., brought malpractice claims against two groups of lawyers who worked at the same firm when the representation began but split ways when the underlying patent case was on appeal.
Both groups of defendants—the lawyers who continued representing Tamai after the breakup and their former colleagues who stopped representing him at that point—raised statute of limitations defenses.
The plaintiffs countered that the continuous representation rule tolled the malpractice statute of limitations while the patent dispute was on appeal.
The court agreed, to an extent. It said the continuous representation rule tolled the limitations period for claims against the lawyers who took the patent case with them after their firm dissolved, but did not toll other claims against the other defendants.
“We join other courts in holding that the continuous-representation rule does not toll the statute of limitations on a claim against a firm after the attorney providing the representation leaves the firm and takes the client's business with her,” Srinivasan wrote, citing Dunn v. Rockwell, 689 S.E.2d 255, 25 Law. Man. Prof. Conduct 681 (W. Va. 2009) and Beal Bank, SSB v. Arter & Hadden LLP, 167 P.3d 666, 23 Law. Man. Prof. Conduct 491 (Cal. 2007).
To contact the reporter on this story: Samson Habte in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Ethan Bowers at email@example.com
Copyright © 2016 American Bar Association and The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)